Filter News
Area of Research
- (-) Clean Energy (73)
- (-) Neutron Science (49)
- (-) Nuclear Science and Technology (9)
- Advanced Manufacturing (9)
- Biology and Environment (20)
- Computational Engineering (1)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Isotopes (8)
- Materials (47)
- Materials for Computing (7)
- National Security (15)
- Quantum information Science (2)
- Supercomputing (50)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (34)
- (-) Artificial Intelligence (6)
- (-) Clean Water (1)
- (-) Computer Science (14)
- (-) Fossil Energy (1)
- (-) Grid (11)
- (-) Isotopes (3)
- (-) Neutron Science (44)
- (-) Space Exploration (3)
- (-) Sustainable Energy (28)
- Advanced Reactors (5)
- Big Data (4)
- Bioenergy (15)
- Biology (9)
- Biomedical (8)
- Biotechnology (3)
- Buildings (10)
- Chemical Sciences (11)
- Climate Change (8)
- Composites (7)
- Coronavirus (9)
- Critical Materials (4)
- Cybersecurity (5)
- Decarbonization (12)
- Energy Storage (28)
- Environment (20)
- Exascale Computing (2)
- Frontier (3)
- Fusion (3)
- High-Performance Computing (4)
- Machine Learning (5)
- Materials (22)
- Materials Science (25)
- Mercury (1)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (5)
- Net Zero (1)
- Nuclear Energy (12)
- Partnerships (8)
- Physics (8)
- Polymers (5)
- Quantum Science (5)
- Renewable Energy (1)
- Security (4)
- Simulation (2)
- Summit (5)
- Transformational Challenge Reactor (3)
- Transportation (20)
Media Contacts
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
Researchers at ORNL have been leading a project to understand how a high-altitude electromagnetic pulse, or EMP, could threaten power plants.
The Hub & Spoke Sustainable Materials & Manufacturing Alliance for Renewable Technologies, or SM2ART, program has been honored with the composites industry’s Combined Strength Award at the Composites and Advanced Materials Expo, or CAMX, 2023 in Atlanta. This distinction goes to the team that applies their knowledge, resources and talent to solve a problem by making the best use of composites materials.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
Sreenivasa Jaldanki, a researcher in the Grid Systems Modeling and Controls group at the Department of Energy’s Oak Ridge National Laboratory, was recently elevated to senior membership in the Institute of Electrical and Electronics Engineers, or IEEE.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A licensing agreement between the Department of Energy’s Oak Ridge National Laboratory and research partner ZEISS will enable industrial X-ray computed tomography, or CT, to perform rapid evaluations of 3D-printed components using ORNL’s machine
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.